London Daily

Focus on the big picture.
Monday, Jul 21, 2025

Australia's International Student Return Plan Likely To Exclude Chinese

Australia's International Student Return Plan Likely To Exclude Chinese

Though Chinese nationals make up most of Australia's international students, they are unlikely to return due to ineligibility of China's Covid vaccines.
A pilot program to allow some international students to return to Australia's most populous state is likely to exclude Chinese nationals due to rules surrounding vaccination status.

The phased plan was approved by the federal government and the first flight carrying some 500 fully-vaccinated international students will arrive in New South Wales by the end of the year, the state government said Friday. Chinese nationals are Australia's biggest source of international students but they are likely to be ineligible to participate, because China's vaccines are not recognized by Australia's Therapeutic Goods Administration.

"They will need to be double vaccinated with a vaccine that our federal authorities deemed to be adequate and effective and that is just the way it is," Premier Gladys Berejiklian told reporters. Those wanting to participate in the future need to "find access to a vaccine that is regarded as effective by our authorities. We don't want additional risk put into our system," she said.

International education was worth A$14.6 billion ($10.7 billion) to New South Wales in 2019, the state government said. Macquarie University, The University of Newcastle, The University of Sydney, University of New South Wales (UNSW) and University of Technology Sydney (UTS) are among the universities that will participate in the pilot plan.

More than 57,000 students are estimated to be overseas, according to the state government. Chinese nationals are Australia's biggest source of international students followed by those in India, Nepal and Vietnam, according to the Australian Trade Department.

Vaccines made by Beijing-based Sinovac Biotech Ltd. and state-owned Sinopharm are among the most used in China, and have efficacy rates ranging from around 50% to 80% in preventing symptomatic Covid. A vaccine developed by Sichuan Clover Biopharmaceuticals was found to prevent 79% of Covid-19 cases caused by the delta strain in late-stage trials.

Sinovac and Sinopharm have provided little conclusive data on the effectiveness of their shots against the delta variant, which is more infectious than the virus' original strain and appears to have dimmed the protection of existing vaccines.

New South Wales state capital Sydney has been at the epicenter of a delta outbreak that's forced Australia's largest city into lockdown for the past 90 days and spread to Melbourne and other east coast areas. On Friday, New South Wales reported 1,043 new Covid-19 cases in 24 hours, with 11 deaths. Victoria, Australia's second-most populous state, reported 733 new cases and 1 death.
Newsletter

Related Articles

0:00
0:00
Close
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
Iranian President Reportedly Injured During Israeli Strike on Secret Facility
EU Delays Retaliatory Tariffs Amid New U.S. Threats on Imports
Trump Defends Attorney General Pam Bondi Amid Epstein Memo Backlash
Renault Shares Drop as CEO Luca de Meo Announces Departure Amid Reports of Move to Kering
Senior Aides for King Charles and Prince Harry Hold Secret Peace Summit
Anti‑Semitism ‘Normalised’ in Middle‑Class Britain, Says Commission Co‑Chair
King Charles Meets David Beckham at Chelsea Flower Show
If the Department is Really About Justice: Ghislaine Maxwell Should Be Freed Now
NYC Candidate Zohran Mamdani’s ‘Antifada’ Remarks Spark National Debate on Political Language and Economic Policy
×